Sanofi

Pursue Progress. Discover Extraordinary.

Science has been our calling from the beginning. Sanofi’s heritage of turning the impossible into the possible stretches back to the 19th century — a rich history of healthcare innovation built by diverse companies united by one shared purpose. More than 150 years later, that spirit lives in everything we do and every person we serve — from the patients who take our medicines, to the healthcare professionals who trust us, to the 83,000+ employees and communities around the world who make it all possible. And today, we’re writing the next chapter of that legacy.

We are an R&D-driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth.

Better is out there. Better medications, better outcomes, better science. And it all starts with people like you — from different backgrounds, in different locations, doing different roles — united by a single mission: we chase the miracles of science to improve people’s lives.

Take the most important step in your career and help us change the lives of patients, families, and communities for the better.

Explore Open Roles →

  • Featured Employer
What could we achieve together? Sign up today and discover our latest opportunities as soon as they’re available.
Reinvention is in our DNA. It’s what drove our evolution from a small French enterprise to one of the world’s leading biopharma companies — present in 70+ countries and growing. Whether it’s harnessing AI to shorten drug-discovery timelines, pioneering transformative treatments, or building trust in healthcare systems worldwide, you could be helping our teams make life better for patients, partners, and communities.

This is where you grow your career. We open the door for you to explore new roles, take on stretch assignments, and connect with people driven by a shared purpose. Our culture of high performance and belonging is grounded in four core values:: Aim Higher, Act for Patients, Be Bold, and Lead Together.

At Sanofi, we believe every person can lead from where they are. You’ll learn to grow your skills and evolve as a leader through our Leadership Frame. Connect with mentors via our Career Hub, and explore new possibilities through “gigs”, where you’ll work on short-term projects to try something new on another team. You’ll do it all with our full support, increasing your exposure to business leaders, and expanding your network across the industry.
All Well, together. We support healthy bodies, healthy minds, healthy financials, and a healthy working culture for all Sanofians. Our dedication to improving people’s lives starts at home, with the health and wellbeing of our employees and their families.
We want you to share your voice and challenge us, even when it might feel uncomfortable. We’ll help turn your ideas into action, based on tangible measures. Because it’s action, not intent, that makes change sustainable and gives us our Diversity Edge.

We’re the first in pharma to have a Diversity, Equity and Inclusion (DE&I) Board with external members. And every member of our Executive Committee is represented either on the DE&I board or as a sponsor of a global Employee Resource Group (ERG). Diversity is our strength. Boldly, proudly and unapologetically. We’re All In on DE&I. Come and be part of it.
What is the Sanofi Feeling?

You are unique. How you feel on any given day is unique. Who you are with, and the environment you’re in, has the power to shape and enhance how you feel. At Sanofi, it’s not just about the chair you sit in. We’ve blended art with science and looked at every detail to match your uniqueness.

We’re transforming healthcare and improving lives through our work, our people, and our stories. You’ll get a glimpse of what life here is like, you’ll hear inspiring stories and you’ll dive into the projects that reveal the miracles of science. Let’s live extraordinarily.
AWARDS
  • Sanofi Human Rights Campaign award.png
  • Sanofi award_usa-2.png
  • Sanofi award_usa-3.png
  • 2023 Best Places to Work
  • 2022 Best Places to Work
NEWS
Merck’s Keytruda holds on to the top spot while AbbVie’s Humira—once the world’s top-selling drug—continues to cede its market share to biosimilar competitors.
Merilog’s approval comes as the insulin space has over the past year suffered several setbacks, including strong calls for price caps and, potentially, the rise of the mammoth GLP-1 market.
Biopharma doubles down on immunology and inflammation as companies target new pathways and seek to improve on current options in inflammatory bowel disease, atopic dermatitis, myasthenia gravis and more.
Without providing specific data, Sanofi on Thursday announced that the experimental vaccine did not significantly prevent invasive E. coli disease versus placebo.
Novartis, Eli Lilly and more put on their deal-making caps, Bristol Myers Squibb targets $2 billion in savings through 2027, sales continue to soar for Lilly and Novo Nordisk’s GLP-1s and Regeneron sues Sanofi over an alleged failure to provide adequate information about Dupixent sales.
According to the lawsuit, Sanofi has failed to provide partner Regeneron adequate information regarding the sales of Dupixent—including agreements with payers and pharmacy benefit managers that determine pricing and rebates for the drug.
There are currently no treatments available for celiac disease beyond a gluten-free diet. Several late-phase companies aim to change the paradigm and deliver hope and progress soon.
Among the FDA’s pending decisions for this quarter are Vertex’s non-opioid pain drug and Sanofi’s RNA interference therapy for hemophilia A and B.
Vertex may have pivoted away from the space, but candidates in development by Arrowhead/Takeda, Wave, Korro and others could address the damage underlying alpha-1 antitrypsin deficiency and make today’s treatments a thing of the past.
JOBS
IN THE PRESS